Mohamad Zoghbi

Biomarkers in Clear Cell Renal Cell Carcinoma: From Biological Association to Clinical Decision-Making

Therapeutic options in renal cell carcinoma (RCC) have expanded rapidly, including adjuvant pembrolizumab, HIF-2α-directed therapy, and multiple effective first-line combinations for metastatic clear-cell RCC (ccRCC), yet treatment selection remains largely clinicopathologic. Thi...